Regulatory & Legal

A new, fully customizable quantum system promises to democratize R&D, fueling national strategies and accelerating discovery in science and medicine.

A new partnership between Telix and Varian aims to fuse precision diagnostics with adaptive radiotherapy, a strategic move set to disrupt the cancer care market.

India's new Labour Code 2025 is forcing a strategic pivot. Discover how firms are turning regulatory mandates into a competitive edge for productivity.

As drone attacks paralyze European airports, an Israeli tech firm's 'soft kill' net system emerges as a key contender for NATO's defense strategy.

MediWound's burn treatment now prevents traumatic tattoos from blasts and accidents, signaling a major strategic expansion and a new era in trauma care.

Herbalife's new podcast with Paralympian Palak Kohli reveals a deeper trend: how corporate content is fueling a new ecosystem for para-athletes in India.

Chemical giant Nouryon is doubling down on Brazil, building a new innovation hub to co-create sustainable beauty and cleaning products for a booming market.

Commercial Metals Company's fourth responsibility award isn't just PR. We decode how its deep ESG integration is a strategic moat in a changing market.

A Texas battery plant is online in record time thanks to a Chinese robotics firm. Discover the 'factory in a box' strategy transforming industrial deployment.

A novel drug for heart failure shows promising safety and efficacy data, potentially disrupting a multi-billion dollar market and validating a key investor's strategy.

Hexagon Purus erases a $12.9M debt in its Panasonic battery deal but gives up lucrative US tax credits, a move securing its supply chain at a high cost.

Denali Therapeutics raises $200M to advance its brain-penetrating drugs, betting big on its pipeline despite short-term market jitters.

Following stellar clinical data, Terns Pharmaceuticals' upsized $650M offering signals massive investor confidence and funds its push to disrupt the CML market.

A 1.01 Tbps cyberattack was just a skirmish in a wider war. See how advanced AI and massive defenses are the new front line against digital extortion.

CEO Adrian Mendes' major buy-in signals deep confidence as Perimeter Medical AI navigates FDA approval for its game-changing cancer surgery technology.

After a 94% stock collapse, 707 Cayman asks shareholders to approve a risky financing deal. Is this a necessary move for survival or a costly dilution?

Beyond bureaucracy, a federal push for bilingual services aims to dismantle linguistic barriers, impacting health equity for minority communities across Canada.

A regulatory filing from Balyasny Asset Management reveals intense investor activity as a bidding war for narcolepsy drugmaker Avadel heats up.

Abundia Global Impact Group and Alterra Energy are building a major plastics-to-fuel facility, a bold move to reshape the Gulf Coast's energy landscape.

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.